Meribank Biotech Co., Ltd (TPEX:4724)
Taiwan · Delayed Price · Currency is TWD 14.85
-0.55 (-3.57%)
Jan 22, 2026, 1:12 PM CST
Meribank Biotech Market Cap
Meribank Biotech has a market cap or net worth of 1.35 billion as of January 21, 2026. Its market cap has decreased by -46.71% in one year.
Market Cap
1.35B
Enterprise Value
2.37B
Revenue
486.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.85
Market Cap Chart
Since June 16, 2023, Meribank Biotech's market cap has decreased from 1.95B to 1.35B, a decrease of -30.38%. That is a compound annual growth rate of -12.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 1.35B | -5.81% |
| Dec 31, 2025 | 1.44B | -41.61% |
| Dec 31, 2024 | 2.46B | 2.99% |
| Dec 29, 2023 | 2.39B | 22.90% |
| Jun 16, 2023 | 1.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeoCore Technology | 1.58B |
| Advagene Biopharma | 1.56B |
| GenMont Biotech Incorporation | 1.55B |
| Enimmune corporation | 1.51B |
| Abnova (Taiwan) | 1.47B |
| Lukas Biomedical | 1.26B |
| GeneReach Biotechnology | 1.13B |
| Taiwan Advance Bio-Pharmaceutical | 1.08B |